Jove
Visualize
Contact Us

Related Experiment Videos

Lessons from sclerosing bone dysplasias.

Wim Van Hul1

  • 1Department of Medical Genetics, University of Antwerp, Antwerp, Belgium. wim.vanhul@ua.ac.be

Hormone Research
|February 7, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Melanocortin 3 Receptors Do Not Specifically Localize to Primary Cilia in Cultured Human and Rodent Neurons.

Cell biochemistry and function·2026
Same author

The Paraoxonase (<i>PON</i>) Gene Family in Health, Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Other Diseases.

International journal of molecular sciences·2025
Same author

The preclinical discovery and development of romosozumab for the treatment of people with severe osteoporosis who are at high risk of fracture.

Expert opinion on drug discovery·2025
Same author

Gradual DNA methylation changes reveal transcription factors implicated in metabolic dysfunction-associated steatotic liver disease progression and epigenetic age acceleration.

Clinical epigenetics·2025
Same author

Loss of the Ubiquitin-Associated Domain of sqstm1/p62 in Zebrafish Causes a Phenotype Resembling Paget's Disease of Bone.

Calcified tissue international·2025
Same author

A Case-Control Study Supports Genetic Contribution of the <i>PON</i> Gene Family in Obesity and Metabolic Dysfunction Associated Steatotic Liver Disease.

Antioxidants (Basel, Switzerland)·2024
Same journal

Abstracts of the LWPES/ESPE 8th Joint Meeting Global Care in Paediatric Endocrinology, in collaboration with APEG, APPES, JSPE and SLEP. New York City, New York, USA. September 9-12, 2009.

Hormone research·2011
Same journal

Abstracts of the 47th Annual Meeting of the European Society for Paediatric Endocrinology (ESPE). Istanbul, Turkey. September 20-23, 2008.

Hormone research·2011
Same journal

Abstracts of the 46th Annual Meeting of the European Society for Paediatric Endocrinology (ESPE). Helsinki, Finland. June 27-30, 2007.

Hormone research·2011
Same journal

Genetic and pathogenetic aspects of Noonan syndrome and related disorders.

Hormone research·2009
Same journal

Response to growth hormone in short children with Noonan syndrome: correlation to genotype.

Hormone research·2009
Same journal

Growth hormone and the heart in Noonan syndrome.

Hormone research·2009
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Genetic factors significantly impact bone mineral density (BMD), with single-gene mutations causing various bone conditions. Understanding these genetic links aids patient evaluation and identifies new osteoporosis treatments.

Area of Science:

  • Genetics
  • Bone Biology
  • Molecular Pathogenesis

Background:

  • Bone mineral density (BMD) is influenced by genetic and environmental factors.
  • Genetic conditions, often monogenic, highlight the role of specific genes in bone homeostasis.
  • Studying these genetic disorders provides insights into the molecular basis of abnormal BMD.

Purpose of the Study:

  • To explore the genetic underpinnings of bone mineral density variations.
  • To understand the molecular pathogenesis of genetic bone disorders.
  • To identify potential therapeutic targets for osteoporosis.

Main Methods:

  • Review of genetic studies on bone mineral density.
  • Analysis of monogenic conditions affecting bone homeostasis.

Related Experiment Videos

  • Molecular evaluation of patients with genetic bone disorders.

    • Main Results:

    • Identification of specific genes influencing bone mineral density.
    • Elucidation of molecular pathways disrupted in genetic bone diseases.
    • Correlation between genetic mutations and abnormal BMD phenotypes.

    Conclusions:

    • Breakthroughs in molecular pathogenesis enable patient evaluation and genetic counseling.
    • Genetic insights into bone metabolism offer promising therapeutic targets for osteoporosis.
    • Understanding monogenic bone disorders advances the treatment of osteoporotic disorders.